top of page

Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

  • Writer: Givol Moked01
    Givol Moked01
  • May 1
  • 0 min read

 
 
bottom of page